Virtu Financial LLC Cyclerion Therapeutics, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.42 - $18.8 $20,380 - $912,251	48,524 New	48,524 $32,000
Q4 2021 Feb 17, 2022	SELL	$1.56 - $2.99 $86,269 - $165,349	-55,301 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.73 - $4.13 $68,476 - $103,592	-25,083 Reduced 31.2%	55,301 $170,000
Q2 2021 Sep 17, 2021	SELL	$2.18 - $4.29 $17,804 - $35,036	-8,167 Reduced 9.22%	80,384 $313,000
Q1 2021 May 19, 2021	BUY	$2.69 - $5.12 $238,202 - $453,381	88,551 New	88,551 $247,000
Q4 2020 Feb 24, 2021	SELL	$2.25 - $7.12 $23,202 - $73,421	-10,312 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$3.46 - $8.39 $35,679 - $86,517	10,312 New	10,312 $63,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $153M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.